Xencor reported $-38348000 in EBIT for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Alnylam Pharmaceuticals ALNY:US USD -258040000 66.35M
Amgen AMGN:US USD 2.23B 436M
AstraZeneca AZN:LN USD 2.26B 427M
Biogen BIIB:US USD 872.1M 68.8M
Bristol Myers Squibb BMY:US USD 2.32B 418M
Cytokinetics CYTK:US USD -108441000 97.57M
GlaxoSmithKline GSK:LN GBP 1.44B 967M
Johnson & Johnson JNJ:US USD 6.27B 572M
Karyopharm Therapeutics KPTI:US USD -30839000 12.07M
Macrogenics MGNX:US USD -24955000 16.85M
Merk MRK:US USD 4.81B 725M
Novartis NOVN:VX USD 3.1B 228M
Pfizer PFE:US USD 5.81B 3.89B
Regeneron Pharmaceuticals REGN:US USD 1.18B 46.9M
Roche Holding ROG:VX 11.54B 2.84B
Seattle Genetics SGEN:US USD -192805000 59.69M
Xencor XNCR:US USD -38348000 10.35M